Midjourney, an artificial intelligence startup known for image generation, has announced a new medical imaging product. The company claims its ultrasound scanner will submerge users in water to deliver MRI-quality scans with the convenience of a spa treatment. CEO David Holz states the device could eventually surpass current magnetic resonance imaging capabilities. This announcement follows the firm’s recent shift away from consumer art tools toward healthcare applications.
Medical specialists remain unconvinced by the lack of public data. Experts told The Verge that while the concept is not dismissed outright, Midjourney has provided little evidence to support its performance claims. The company has shared only controlled tests on imaging phantoms rather than results from human subjects. Without clinical trials or peer-reviewed studies, the assertion that the system offers superior diagnostic power remains unverified. The startup faces significant scrutiny regarding its ability to deliver on these ambitious promises.
- The device requires full-body immersion in water.
- Current validation relies on phantom segmentation tests.
- No clinical trials have been published yet.
